Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
about
Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it?Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaBoosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturationThe MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiationAnalysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR)USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcomeInhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection.Differential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas.Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactionsBlood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantationA cytokine-mediated link between innate immunity, inflammation, and cancer.Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review).Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease.IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytomaAntibodies to placental immunoregulatory ferritin with transfer of polyclonal lymphocytes arrest MCF-7 human breast cancer growth in a nude mouse modelPancreatic ductal adenocarcinoma: a review of immunologic aspects.Stress significantly increases mortality following a secondary bacterial respiratory infectionSerum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-AnalysisResolution of a chronic viral infection after interleukin-10 receptor blockadeDendritic cell dysfunction in cancer: a mechanism for immunosuppression.Interleukin-10 and the immune response against cancer: a counterpoint.Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic HepatitisInflammatory events during murine squamous cell carcinoma development.The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database studyExpanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.From cancer immunosurveillance to cancer immunotherapy.Cytokines and Prognostic Factors in Epithelial Ovarian Cancer.A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome.Cell type-specific regulation of IL-10 expression in inflammation and disease.Prognostic value of PDL1 expression in pancreatic cancerImproving cancer immunotherapy by targeting tumor-induced immune suppression.The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcomeThe role of the mediators of inflammation in cancer development.Wilms' tumor protein Wt1 regulates the Interleukin-10 (IL-10) gene.Interleukin-10 ablation promotes tumor development, growth, and metastasis.Update: Cytokine Dysregulation in Chronic Nonbacterial Osteomyelitis (CNO)
P2860
Q27001221-94519E49-CE7C-4C84-BB53-2883BE04A17FQ27016002-8EA7773C-AF24-44F3-AAE8-6C3571EE31BAQ30482591-0B65E401-0006-4895-9BE1-86EA842F2626Q33326982-EEF6AEA4-D070-43EF-9A05-6F14762A9498Q33749249-4333A3CD-4CDC-4651-9AC5-34520100A761Q33755106-E0614BD9-2B2D-42F7-A85A-BBF0C768ECD9Q33870620-90C2920F-B5A6-4544-8C33-BB75EB137B11Q33903025-42D8E132-D387-443F-9847-D826412CC53FQ34353489-4FEBFF67-97E1-4353-8347-792432724003Q34464484-715DDFFC-7147-49A4-9B1C-98F1D1289981Q34477550-C66DF70E-6807-4322-99E4-87B088666186Q34618829-74AFCFC1-0A01-4145-A19B-B25D1C877CACQ34625152-CEB71CD7-84DC-4E81-B201-4C17A768E604Q35042272-51889B41-28C2-41C8-A177-DB58C065C9C2Q35690113-1E0DFBD5-D0AA-43F6-B9DF-92985291D696Q35799158-553C214B-4962-4261-A1E7-A4387D9E088CQ35855097-6F7A3744-4AE5-4EFA-96BB-1ED600326714Q35870682-EE447493-CA36-4C1D-A48B-706D50830304Q35946006-0410C290-9E2F-4468-83F7-202A66C3367FQ36127128-61FCC54A-77FA-462C-BDF8-6E58E6685635Q36228023-7A320952-97A2-4474-8B2B-14AFEA8B3350Q36262281-485C051D-0574-4120-8A15-CB3DF96EDAF1Q36276594-3FCA590B-EC0E-412C-B2F5-027295C9087FQ36418044-A0FEB5E6-0719-482B-B8E1-ABB1B64AF6E3Q36523752-4379BB5A-0E37-4D6A-A6B5-ABFBBDA8AD80Q36671917-2795EDC0-2039-49FB-98D5-55601A710C77Q36715205-C62F19ED-C5C6-4336-9E3C-C1774EF229ECQ36990588-D81ABFA3-C272-4308-B9F4-74D5E81A1E47Q37152508-C6EB7BA5-8E87-4A0A-83D8-C6C2944388FAQ37386071-1C1035E4-8C35-4372-B554-3B035A4E86C7Q37678256-4F4075D8-4B07-42C3-AEA4-7D1B96956A94Q37687595-C5624A7C-5E14-48AD-A712-5DC5094A98F9Q37830362-B29704B8-7268-4103-A87C-3E2AB95D0540Q38025405-91F02827-0894-4527-8767-3F94F3FF4521Q38367696-40BF738E-A263-4689-968E-80AD72D59BD2Q39640174-4FBFFB76-95AD-4DD4-8429-927212F3AAA8Q40507111-B7BD2593-4A83-49DE-BC64-543F5875B240Q42182068-959DEAD6-A3FF-48AB-81B0-59A3575CA4CB
P2860
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
@ast
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
@en
type
label
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
@ast
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
@en
prefLabel
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
@ast
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
@en
P2860
P1476
Interleukin-10 in viral diseases and cancer: exiting the labyrinth?
@en
P2093
Alain P Vicari
Giorgio Trinchieri
P2860
P304
P356
10.1111/J.0105-2896.2004.00216.X
P577
2004-12-01T00:00:00Z